Central nervous system-targeted expression of the complement inhibitor scrry prevents experimental allergic encephalomyelitis

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6551-6556

  Davoust, Nathalie ^a   Nataf, Serge ^a   Reiman, Rachael ^a   Holers, Michael V ^b   Campbell, Iain L ^c   Barnum, Scott R ^a,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; HUMORAL IMMUNITY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CEREBELLUM; COMPLEMENT C4; DNA, COMPLEMENTARY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN-ASSOCIATED GLYCOPROTEIN; PROMOTER REGIONS (GENETICS); RECEPTORS, COMPLEMENT;

EID: 0032736185     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lassmann, H., C. S. Raine, J. Antel, and J. W. Prineas. 1998. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J. Neuroimmunol. 86:213.
2. Shin, M. L., H. Rus, and F. Niculescu. 1998. The Human Complement System in Health and Disease J. E. Volanakis and M. M. Frank, eds. Marcel Dekker, New York, p. 499.
3. Stinissen, P., R. Medaer, and J. Raus. 1998. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis. Mult. Scler. 4:203.
4. Ewing, C., and C. C. Bernard. 1998. Insights into the etiology and pathogenesis of multiple sclerosis. Immunol. Cell Biol. 76:47.
5. Hjelmström, P., A. E. Juedes, J. Fjell, and N. H. Ruddle. 1998. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161:4480.
6. Hjelmström, P., A. E. Juedes, and N. H. Ruddle. 1998. Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis. Res. Immunol. 149:794.
7. Steinman, L. 1997. Some misconceptions about understanding autoimmunity through experiments with knockouts. J. Exp. Med. 185:2039.
8. Morgan, B. P., P. Gasque, S. Singhrao, and S. J. Piddlesden. 1997. The role of complement in disorders of the nervous system. Immunopharmacology 38:43.
9. Spiegel K., M. R. Emmerling, and S. R. Barnum. 1997. Acute phase proteins: strategies for inhibition of complement activation in the treatment of neurodegenerative disorders. In Inflammatory Mechanisms and Management of Neurodegeneration. P. Wood, ed. Humana Press, Totowa, NJ, p. 129.
10. Linington, C., B. P. Morgan, N. J. Scolding, P. Wilkins, S. Piddlesden, and D. A. Compston. 1989. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112:895.
11. Piddlesden, S., H. Lassmann, I. Laffafian, B. P. Morgan, and C. Linington. 1991. Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Clin. Exp. Immunol. 83:245.
12. Piddlesden, S. J., M. K. Storch, M. Hibbs, A. M. Freeman, H. Lassmann, and B. P Morgan. 1994. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152:5477.
13. Kim, Y. U., T. Kinoshita, H. Molina, D. Hourcade, T. Seya, L. M. Wagner, and V. M. Holers. 1995. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181:151.
14. Quigg, R. J., C. He, A. Lim, D. Berthiaume, J. J. Alexander, D. Kraus, and V. M. Holers. 1998. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J. Exp. Med. 188:1321.
15. Stalder, A. K., M. J. Carson, A. Pagenstecher, V. C. Asensio, C. Kincaid, M. Benedict, H. C. Powell, E. Masliah, and I. L. Campbell. 1998. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am. J. Pathol. 153:767.
16. Davoust, N., S. Nataf, M. V. Holers, and S. R. Barnum. 1999. Expression of the murine complement regulatory protein Crry by glial cells and neurons. Glia 27:162.
17. Liu, J., M. W. Marino, G. Wong, D. Grail, A. Dunn, J. Bettadapura, A. J. Slavin, L. Old, and C. C. Bernard. 1998. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:78.
18. Bernard, C. C., T. G. Johns, A. Slavin, M. Ichikawa, C. Ewing, J. Liu, and J. Bettadapura. 1997. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75:77.
19. Nataf, S., N. Davoust, R. Ames, and S. R. Barnum. 1998. Human T-cells express the C5a receptor and are chemoattracted to C5a. J. Immunol. 162:4018.
20. Nataf, S., Stahel, P. F., Davoust, N., and S. R. Barnum. 1999. Complement anaphylatoxin receptor expression on neurons: new tricks for old receptors? Trends Neurosci. 22:397.
21. Foreman, K. E., A. A. Vaporciyan, B. K. Bonish, M. L. Jones, K. J. Johnson, M. M. Glovsky, S. M. Eddy, and P. A. Ward. 1994. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1147.
22. McCoy, R., D. L. Haviland, E. P. Molmenti, T. Ziambaras, R. A. Wetsel, and D. H. Perlmutter. 1995. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182:207.
23. Ember J. A., M. A. Jagels, and T. E. Hugli. 1998. Characterization of complement anaphylatoxins and their biological responses. In The Human Complement System in Health and Disease. J. E. Volanakis and M. M. Frank, eds. Marcel Dekker, NY, p. 241.
24. Czermak, B. J., V. Sarma, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. In vitro and In vivo dependency of chemokine generation on C5a and TNF-α. J. Immunol. 162:2321.
25. Archelos, J. J., S. C. Previtali, and H.-P. Hartung. 1999. The role of integrins in immune-mediated diseases of the nervous system. Trends Neurosci. 22:30.
26. Stahel, P. F., M. C. Morganti-Kossmann, and T. Kossmann. 1998. The role of the complement system in traumatic brain injury. Brain Res. Rev. 27:243.